So, we wondered if IL-32γ contributes to play a tumoricidal role through arrest of cancer stem cells at the G2/M checkpoint of the cell cycle, and the cell-cycle distribution of CD133+ cells after IL-32γ induction was analyzed through FACS assay. The gene discussed is PROM1; the disease is cancer.